These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 19861858

  • 1. Mycophenolate sodium increases cyclosporine blood levels in renal transplant recipients.
    Pourfarziani V, Taheri S.
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):991-4. PubMed ID: 19861858
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of changing from cyclosporine C0 to C2 monitoring in stable recipients following renal transplantation: a prospective cohort study.
    Zhang Y, Zhang XD, Wang Y.
    Transplant Proc; 2011 Dec; 43(10):3697-701. PubMed ID: 22172829
    [Abstract] [Full Text] [Related]

  • 3. Long-term comparative results of C0 and C2 monitoring of CyA in renal transplanted patients.
    Paydaş S, Balal M, Sertdemir Y, Seyrek N, Karayaylali I.
    Ren Fail; 2005 Dec; 27(4):409-13. PubMed ID: 16060128
    [Abstract] [Full Text] [Related]

  • 4. Role of postdose cyclosporine monitoring in living renal transplant recipients.
    Thomas R, Minz M, Singh B, Heer M, Kashyap R.
    Transplant Proc; 2004 Sep; 36(7):2104. PubMed ID: 15518761
    [Abstract] [Full Text] [Related]

  • 5. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
    Loichot C, Bentue-Ferrer D, Bernard N, Bonardet A, Boulieu R, Kergueris MF, Paintaud G, Peytavin G, Simon N, Marquet P, Therapeutic Drug Monitoring Group of the French Pharmacological Society.
    Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
    [Abstract] [Full Text] [Related]

  • 6. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 7. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
    Sukhavasharin N, Praditpornsilpa K, Avihingsanon Y, Kuoatawintu P, O-Charoen R, Kansanabuch T, Tungsanga K, Eiam-Ong S.
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
    [Abstract] [Full Text] [Related]

  • 8. Comparative analysis of azathioprine versus cyclosporine-based therapy in primary haplo-identical live-donor kidney transplantation: a 20-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Sobh M, Ghoneim M.
    Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):564-70. PubMed ID: 18580014
    [Abstract] [Full Text] [Related]

  • 9. Minimization of maintenance immunosuppression early after renal transplantation: an interim analysis.
    Bemelman FJ, de Maar EF, Press RR, van Kan HJ, ten Berge IJ, Homan van der Heide JJ, de Fijter HW.
    Transplantation; 2009 Aug 15; 88(3):421-8. PubMed ID: 19667948
    [Abstract] [Full Text] [Related]

  • 10. Blood cyclosporine level soon after kidney transplantation is a major determinant of rejection: insights from the Mycophenolate Steroid-Sparing Trial.
    Gotti E, Perico N, Gaspari F, Cattaneo D, Lesti MD, Ruggenenti P, Segoloni G, Salvadori M, Rigotti P, Valente U, Donati D, Sandrini S, Federico S, Sparacino V, Mourad G, Bosmans JL, Dimitrov BD, Iordache BE, Remuzzi G.
    Transplant Proc; 2005 Jun 15; 37(5):2037-40. PubMed ID: 15964332
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of enteric-coated mycophenolate sodium in de novo and maintenance renal transplant patients.
    Nart A, Sipahi S, Aykas A, Uslu A, Hoşcoşkun C, Toz H.
    Transplant Proc; 2008 Jun 15; 40(1):189-92. PubMed ID: 18261583
    [Abstract] [Full Text] [Related]

  • 12. Comparison of cyclosporine concentrations 2 hours post-dose determined using 3 different methods and trough level in pediatric renal transplantation.
    Rodríguez E, Delucchi MA, Cano F, Valdebenito S, Castillo MC, Villegas R.
    Transplant Proc; 2005 Oct 15; 37(8):3354-7. PubMed ID: 16298594
    [Abstract] [Full Text] [Related]

  • 13. Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study.
    Kyllönen LE, Salmela KT.
    Transplantation; 2006 Apr 15; 81(7):1010-5. PubMed ID: 16612277
    [Abstract] [Full Text] [Related]

  • 14. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
    Delgado DH, Rao V, Hamel J, Miriuka S, Cusimano RJ, Ross HJ.
    J Heart Lung Transplant; 2005 Sep 15; 24(9):1343-6. PubMed ID: 16143255
    [Abstract] [Full Text] [Related]

  • 15. CYP3A5 polymorphism effect on cyclosporine pharmacokinetics in living donor renal transplant recipients: analysis by population pharmacokinetics.
    Song J, Kim MG, Choi B, Han NY, Yun HY, Yoon JH, Oh JM.
    Ann Pharmacother; 2012 Sep 15; 46(9):1141-51. PubMed ID: 22947591
    [Abstract] [Full Text] [Related]

  • 16. The area under the concentration-time curve versus trough and peak blood level monitoring in renal transplant recipients on cyclosporine.
    Halim MA, Nampoory MR, Johny KV, Donia F, Hamid MH, Said T, Nair MP, Mansour M, Al-Muzairai I, Samhan M, Al-Mousawi M.
    Transplant Proc; 2005 Sep 15; 37(7):3019-21. PubMed ID: 16213291
    [Abstract] [Full Text] [Related]

  • 17. Abbreviated AUC monitoring of cyclosporine more adequately identified patients at risk for acute rejection during induction of immunosuppressive therapy after kidney transplantation than recommended C2 concentration values.
    Troncoso P, Ortiz AM, Jara A, Vilches S.
    Transplant Proc; 2009 Sep 15; 41(1):127-30. PubMed ID: 19249495
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine therapeutic monitoring with Cmax in kidney transplant recipients: does it fit for all populations?
    El-Agroudy AE, Ismail AM, Nassar M, Ghoneim MA.
    Exp Clin Transplant; 2008 Dec 15; 6(4):282-6. PubMed ID: 19338490
    [Abstract] [Full Text] [Related]

  • 19. Graft function based on two hours peak level monitoring of cyclosporine A during the first six months of renal transplantation.
    Hami M, Naghibi M, Mojahedi MJ, Sharifipour F, Shakeri MT.
    Saudi J Kidney Dis Transpl; 2012 Nov 15; 23(6):1169-74. PubMed ID: 23168844
    [Abstract] [Full Text] [Related]

  • 20. Limitations of C2 monitoring in renal transplant recipients.
    Einecke G, Schütz M, Mai I, Fritsche L, Giessing M, Glander P, Neumayer HH, Budde K.
    Nephrol Dial Transplant; 2005 Jul 15; 20(7):1463-70. PubMed ID: 15840681
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.